TFF2 and neoplasm: To prove that CD11b+Gr-1+ cells directly contributed to tumour progression, we performed adoptive transfer of MDSC sorted from spleen and bone marrow of tumour-bearing Tff2-null mice into AOM/DSS-treated CD2–Tff2 mice19.